Clinical Trial Update: Danazol for Genetic Bone Marrow and Lung Disorders [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for danazol in aplastic anemia and related bone marrow/lung disorders; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• Danazol (danazol)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Aplastic Anemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-07-11